MENLO PARK, Calif., June 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced positive top-line ...
Mineralys Therapeutics, Inc. announced positive topline results from its pivotal Launch-HTN Phase 3 and Advance-HTN Phase 2 trials, evaluating the efficacy and safety of lorundrostat in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback